Disc Medicine, INC Form 4 insider transactions

William Jacob Savage, Chief Medical Officer of Disc Medicine, Inc., reports selling 6,677 shares of common stock at a weighted average price of $50.0417.

William Jacob Savage, Chief Medical Officer of Disc Medicine, Inc., sold 2,100 shares of common stock on May 2, 2025, under a pre-arranged Rule 10b5-1 trading plan.

John D. Quisel, CEO of Disc Medicine, Inc., exercised stock options on April 7, 2025, acquiring 7,000 shares of common stock at $1.01 per share.

Director Mona Ashiya reports indirect sales of Disc Medicine (IRON) common stock through affiliated entities.

OrbiMed Advisors LLC and related entities report the sale of Disc Medicine, Inc. (IRON) common stock at $54.11 per share.

Director Mona Ashiya reports the sale of Disc Medicine (IRON) shares held indirectly through OrbiMed investment partnerships.

OrbiMed Advisors LLC, along with related entities, reports the sale of Disc Medicine, Inc. (IRON) common stock across multiple transactions between March 19 and March 21, 2025.

Director Mona Ashiya reports multiple sales of Disc Medicine (IRON) common stock between March 10 and March 12, 2025, at prices ranging from $54.01 to $55.05 per share.

OrbiMed Advisors LLC and related entities have sold shares of Disc Medicine, Inc. (IRON) common stock in a series of transactions between March 10, 2025, and March 12, 2025, while maintaining indirect beneficial ownership.

Pamela Stephenson, Chief Commercial Officer of Disc Medicine, Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.

Rahul Khara, Chief Legal Officer of Disc Medicine, Inc., sold shares to cover tax withholding obligations related to vesting restricted stock units.

William Jacob Savage, Chief Medical Officer of Disc Medicine, Inc., sold 1,638 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Disc Medicine's Chief Operating Officer, Jonathan Yen-Wen Yu, sold 1,610 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Jean M. Franchi, CFO of Disc Medicine, Inc., sold 3,136 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

CEO of Disc Medicine, John Quisel, sold shares to cover tax obligations related to vesting restricted stock units.

Pamela Stephenson, Chief Commercial Officer of Disc Medicine, Inc., reports the acquisition of 36,000 shares of common stock and stock options.

Chief Legal Officer Rahul Khara reports acquisition and disposal of Disc Medicine stock and stock options.

Chief Operating Officer of Disc Medicine, Yu Yen-Wen Jonathan, reports acquisition of shares and options in the company.

Chief Financial Officer Jean M. Franchi reports acquiring 36,000 shares of Disc Medicine, Inc. and stock options, according to a recent SEC Form 4 filing.

CEO John Quisel reports acquisition of common stock and stock options in Disc Medicine, Inc.

William Jacob Savage, Chief Medical Officer of Disc Medicine, reports acquisition of common stock and stock options.

Rahul Khara, Chief Legal Officer of Disc Medicine, Inc., exercised stock options and sold shares under a pre-arranged Rule 10b5-1 trading plan.

Disc Medicine's Chief Legal Officer, Rahul Khara, executed multiple stock transactions, including option exercises and sales, under a pre-arranged 10b5-1 trading plan.

Disc Medicine's CEO, John D. Quisel, executed stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Disc Medicine's CEO, John Quisel, exercised stock options and sold shares of common stock on December 23, 2024, under a pre-arranged Rule 10b5-1 trading plan.

Disc Medicine's CEO, John D. Quisel, exercised stock options and sold shares on December 16, 2024, under a pre-arranged 10b5-1 trading plan.

Director William Richard White of Disc Medicine, Inc. executed multiple transactions involving the company's common stock and stock options on December 2, 2024, under a pre-arranged 10b5-1 trading plan.

Disc Medicine's Chief Medical Officer, William Jacob Savage, executed multiple stock transactions, including option exercises and sales, under a pre-arranged 10b5-1 trading plan.

Disc Medicine's Chief Medical Officer, William Jacob Savage, executed multiple stock transactions, including option exercises and sales, under a pre-arranged 10b5-1 trading plan.

Director William Richard White of Disc Medicine, Inc. reports multiple transactions involving common stock and stock options, executed under a pre-arranged Rule 10b5-1 trading plan.